GAD2 and stiff-person syndrome: Noteworthy, the frequency of GAD65 memory cells in healthy controls was similar to that in SPS patients before rituximab treatment, suggesting that B cell tolerance to GAD65 seem not to be imposed during B cell development at the stage of immature or transitional B cells but during the formation of plasma cells in the germinal center reaction.